Viridian Therapeutics is up a bit on the day, funds flowing in kept the price up 1.71% since yesterday. VRDN is near a weak support line. We'll see if it bounces off or heads lower. Viridian Therapeutics hasn't been that impressive in terms of its 3 month momentum, we'll see if it can turn things around and start heading up or continue its slide down.
If we get a reversal off of support and Viridian Therapeutics starts moving up, it can probably get to $18 at which point it'll need to break through that resistance level in order to keep moving higher. If it fails to bounce off this level and breaks down lower, it will most likely find the nearest support a the $13.3
at which point, it may have a chance of recovering from there.
The analysts are pretty neutral on Viridian Therapeutics right now, so not much useful information here. The current Analysts Sentiment Score is 1.01. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Oppenheimer gave a boost to their price target and moved to $36.00 from $35.00 on 2023-12-19. On 2023-12-18 HC Wainwright reiterated their rating of Buy and added a price target of $37.00. Royal Bank of Canada announced that they are reiterating a rating of Outperform on 2023-12-14 and added a price target of $35.00. On 2023-12-04 there was confirmation of the previous rating by Wedbush which was Outperform and provided a price target of $37.00. JMP Securities announced a lowering of their price target to $38.00 from $42.00 on 2023-11-14. Needham & Company LLC dropped their price target by -25% to $30.00 on 2023-10-30. Stifel Nicolaus reiterated a rating of Buy on 2023-09-13 and provided a price target of $40.00. Wells Fargo & Company dropped their price target by -15.22% to $39.00 on 2023-08-09. On 2023-06-14 BTIG Research started covering Viridian Therapeutics with a rating of Buy and added a price target of $46.00. On 2023-03-09 there was confirmation of the previous rating by LADENBURG THALM/SH SH which was Buy and provided a price target of $40.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| VRDN | 1.01 | 1.23 | 0 | 1.24 | -0.45 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| VRDN | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| VRDN | 12.43 | %17.4948 | 11.9 | -24.486 | 7640000 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| VRDN |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
